Pembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study

Simple item page
dc.conference.dateNOV 20-22, 2020
dc.conference.titleESMO Asia Virtual Congress
dc.contributor.authorYoshino, T.
dc.contributor.authorKim, T. W.
dc.contributor.authorYong, W. P.
dc.contributor.authorShiu, K-K.
dc.contributor.authorJensen, B. Vittrup
dc.contributor.authorJensen, L. Henrik
dc.contributor.authorSmith, D.
dc.contributor.authorGarcia-Carbonero, R.
dc.contributor.authorAlcaide-Garcia, J.
dc.contributor.authorGibbs, P.
dc.contributor.authorde la Fouchardiere, C.
dc.contributor.authorRivera, F.
dc.contributor.authorElez, E.
dc.contributor.authorBendell, J.
dc.contributor.authorLe, D. T.
dc.contributor.authorYang, P.
dc.contributor.authorFarooqui, M.
dc.contributor.authorMarinello, P.
dc.contributor.authorDiaz, L. A.
dc.contributor.authorAndre, T.
dc.contributor.authoraffiliation[Yoshino, T.] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Chiba, Japan
dc.contributor.authoraffiliation[Kim, T. W.] Asan Med Ctr, Oncol, Seoul, South Korea
dc.contributor.authoraffiliation[Yong, W. P.] Natl Univ Singapore Hosp, Haematol Oncol, Med Oncol, Singapore, Singapore
dc.contributor.authoraffiliation[Shiu, K-K.] NHS Fdn Trust, Univ Coll Hosp, Med Oncol, London, England
dc.contributor.authoraffiliation[Jensen, B. Vittrup] Herlev & Gentofte Hosp, Med Oncol, Herlev, Denmark
dc.contributor.authoraffiliation[Jensen, L. Henrik] Univ Hosp Southern Denmark, Oncol, Vejle, Denmark
dc.contributor.authoraffiliation[Smith, D.] Hop Haut Leveque, Oncol, Pessac, France
dc.contributor.authoraffiliation[Garcia-Carbonero, R.] UCM, Hosp Univ 12 Octubre, Gastrointestinal Tumor Unit, Imas12, Madrid, Spain
dc.contributor.authoraffiliation[Alcaide-Garcia, J.] Hosp Reg Univ, Med Oncol, Malaga, Spain
dc.contributor.authoraffiliation[Gibbs, P.] Western Hosp, Med Oncol Colorectal Canc, Footscray, Vic, Australia
dc.contributor.authoraffiliation[de la Fouchardiere, C.] Ctr Leon Berard, Med Oncol, Lyon, France
dc.contributor.authoraffiliation[Rivera, F.] IDIVAL, Hosp Univ Marques de Valdecilla, Oncol, Santander, Spain
dc.contributor.authoraffiliation[Elez, E.] Vall dHebron Inst Oncol, Gastrointestinal & Endocrine Tumors Grp, Barcelona, Spain
dc.contributor.authoraffiliation[Bendell, J.] Sarah Cannon Res Inst, Hematol & Med Oncol, Nashville, TN USA
dc.contributor.authoraffiliation[Le, D. T.] Sidney Kimmel Comprehens Canc Ctr, Oncol, Baltimore, MD USA
dc.contributor.authoraffiliation[Yang, P.] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Farooqui, M.] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Marinello, P.] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
dc.contributor.authoraffiliation[Diaz, L. A.] Mem Sloan Kettering Canc Ctr, Solid Tumor Oncol, 1275 York Ave, New York, NY 10021 USA
dc.contributor.authoraffiliation[Andre, T.] Hop St Antoine, Med Oncol, Paris, France
dc.contributor.funderMerck Sharp Dohme Corp.
dc.date.accessioned2025-01-07T12:14:41Z
dc.date.available2025-01-07T12:14:41Z
dc.date.issued2020-11-01
dc.identifier.doi10.1016/j.annonc.2020.10.132
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420426237/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24353
dc.identifier.wosID600988900113
dc.issue.number6
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.page.numberS1284-S1285
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePembrolizumab vs chemotherapy in patients with microsatellite instability-high/mismatch repair deficient metastatic colorectal cancer: Asia subgroup results of the phase III KEYNOTE-177 study
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía